Cargando…

Amyloid fibrils and prefibrillar aggregates : molecular and biological properties /

Summing up almost a decade of biomedical research, this topical handbook is a reference on the topic which incorporates recent breakthroughs in amyloid research. The first part covers the structural biology of amyloid fibrils and pre-fibrillar assemblies. The second part looks at the diagnosis and b...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Otzen, Daniel Erik, 1969-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Weinheim : Wiley-VCH, [2013]
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Amyloid Fibrils and Prefibrillar Aggregates
  • Contents
  • Preface
  • List of Contributors
  • 1 The Amyloid Phenomenon and Its Significance
  • 1.1 Introduction
  • 1.2 The Nature of the Amyloid State of Proteins
  • 1.3 The Structure and Properties of Amyloid Species
  • 1.4 The Kinetics and Mechanism of Amyloid Formation
  • 1.5 The Link between Amyloid Formation and Disease
  • 1.6 Strategies for Therapeutic Intervention
  • 1.7 Looking to the Future
  • 1.8 Summary
  • Acknowledgments
  • References
  • 2 Amyloid Structures at the Atomic Level: Insights from Crystallography
  • 2.1 Atomic Structures of Segments of Amyloid-Forming Proteins
  • 2.1.1 Protein Segments That Form Amyloid-Related Crystals
  • 2.1.2 Atomic Structures of Fiber-Like Microcrystals
  • 2.2 Stability of Amyloid Fibers
  • 2.3 Which Proteins Enter the Amyloid State?
  • 2.4 Molecular Basis of Amyloid Polymorphism and Prion Strains
  • 2.5 Atomic Structures of Steric Zippers Suggest Models for Amyloid Fibers of Parent Proteins
  • 2.6 Atomic Structures of Steric Zippers Offer Approaches for Chemical Interventions against Amyloid Formation
  • 2.7 Summary
  • Acknowledgments
  • References
  • 3 What Does Solid-State NMR Tell Us about Amyloid Structures?
  • 3.1 Introduction
  • 3.2 Principles of Solid-State NMR Spectroscopy and Experiments for Structural Constraints
  • 3.2.1 Isotope Labeling, Magic Angle Spinning, Dipolar Coupling, and Resonance Assignment
  • 3.2.2 De.ning the Amyloid Core by Magnetization Transfer from Water
  • 3.2.3 Determining the Fibril Registry
  • 3.2.4 Seeded versus Unseeded Fibrils
  • 3.3 Amyloid Fibrils Investigated by Solid-State NMR Spectroscopy
  • 3.3.1 AÝ peptides of Different Length
  • 3.3.2 Islet Amyloid Polypeptide (IAPP/Amylin): Parallel and Antiparallel Steric Zippers
  • 3.3.3 Ü-Synuclein: Polymorphism with Flexible Terminal Regions.
  • 3.3.4 PrP: Rearrangements to Maintain a Fibrillar Core Region
  • 3.3.5 Yeast Prions with Glutamine/Asparagine-Rich Prion Domains: Sup35p, Ure2p, and Rnq1p
  • 3.3.6 Functional Amyloid: the Yeast Prion HET-s
  • 3.4 Summary
  • References
  • 4 From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy
  • 4.1 Introduction
  • 4.2 History
  • 4.2.1 The Historical Use of X-ray Fiber Diffraction
  • 4.2.2 The Historical Use of Transmission Electron Microscopy
  • 4.3 Methodology
  • 4.3.1 X-Ray Fiber Diffraction
  • 4.3.2 Transmission Electron Microscopy
  • 4.4 Recent Advances in Amyloid Structure Determination
  • 4.4.1 X-ray Fiber Diffraction
  • 4.4.2 Transmission Electron Microscopy
  • 4.5 Summary
  • Acknowledgments
  • References
  • 5 Structures of Aggregating Species by Small-Angle X-Ray Scattering
  • 5.1 Introduction
  • 5.2 Theoretical and Experimental Aspects
  • 5.3 Data Analysis and Modeling Methods
  • 5.4 Studying Protein Aggregation and Fibrillation Using SAXS
  • 5.4.1 Some General Considerations
  • 5.4.2 SAXS Studies of Insulin, Glucagon, and Ü-Synuclein
  • 5.4.3 SDS-Induced Aggregation of Ü-Synuclein
  • 5.4.4 Multi-Component Fitting and Analysis of SAXS Data
  • 5.5 General Strategies for Modeling SAXS Data from Protein Complexes
  • 5.6 Summary and Final Remarks
  • Acknowledgments
  • References
  • 6 Structural and Compositional Information about Pre-Amyloid Oligomers
  • 6.1 General Introduction
  • 6.2 Biophysical Techniques to Study Amyloid Oligomers
  • 6.2.1 Fluorescence Spectroscopy
  • 6.2.1.1 Ensemble Spectroscopy
  • 6.2.1.2 Single-Molecule Spectroscopy
  • 6.2.2 Atomic Force Microscopy
  • 6.2.3 Absorbance and Circular Dichroism Spectroscopy
  • 6.2.4 Small-Angle X-Ray Scattering
  • 6.2.5 Mass Spectrometry
  • 6.3 The Structure and Composition of Amyloid Oligomers
  • 6.3.1 Ü-Synuclein Oligomers.
  • 6.3.1.1 Morphology
  • 6.3.1.2 Oligomer Structure
  • 6.3.1.3 Oligomer Composition
  • 6.3.2 AÝ Peptide Oligomers
  • 6.3.2.1 Morphology
  • 6.3.2.2 Composition
  • 6.4 Concluding Remarks
  • Acknowledgments
  • References
  • 7 The Oligomer Species: Mechanistics and Biochemistry
  • 7.1 Introduction
  • 7.2 The Structure-Toxicity Relation of Early Amyloids
  • 7.2.1 Antibodies Define Different Structural Classes of Oligomers and Fibrils
  • 7.2.2 Proteins May Form Different Kinds of Oligomers with Different Structural and Biological Activities
  • 7.3 The Oligomer-Membrane Complex
  • 7.3.1 The Effect of Surfaces on Protein Misfolding and Aggregation
  • 7.3.2 The Membrane Composition Affects Binding and Aggregation Processes
  • 7.3.3 Complex Roles of Cholesterol and Gangliosides in Oligomer Cytotoxicity
  • 7.4 Biochemical Modifications Underlying Amyloid Toxicity
  • 7.4.1 A New View of the Amyloid Cascade Hypothesis
  • 7.4.2 Amyloid Pores: a Mechanism for Cytotoxicity?
  • 7.4.3 Other Mechanisms for Oligomer Cytotoxicity
  • 7.4.3.1 Oxidative Stress and Amyloid Aggregates
  • 7.4.3.2 Lipid Modification and Ca2+ Entry
  • 7.4.3.3 The Complexity of Amyloid and Oligomer Polymorphism
  • 7.5 Summary
  • References
  • 8 Pathways of Amyloid Formation
  • 8.1 Introduction
  • 8.2 Nomenclature of the Various Conformational States
  • 8.3 Graphical Representations of the Mechanisms Leading to Amyloid
  • 8.3.1 Time Course of Amyloid Content
  • 8.3.2 Energy Landscapes of Amyloid Fibril Formation
  • 8.3.3 Reaction Equilibria Involved in Amyloid Fibril Formation
  • 8.4 Pathways of Amyloid Fibril Formation
  • 8.5 Nucleation Growth versus Nucleated Conformational Conversion
  • 8.6 Summary
  • References
  • 9 Sequence-Based Prediction of Protein Behavior
  • 9.1 Introduction
  • 9.2 The Strategy of the Zyggregator Predictions.
  • 9.2.1 Prediction of the Effects of Amino Acid Substitutions on Protein Aggregation Rates
  • 9.2.2 Prediction of the Overall Aggregation Rates of Peptides and Proteins
  • 9.2.3 Prediction of Aggregation-Prone Regions in Amino Acid Sequences
  • 9.3 Aggregation Under Other Conditions
  • 9.3.1 Prediction of Protein Aggregation-Prone Regions in the Presence of Denaturants
  • 9.3.2 Prediction of Aggregation-Prone Regions in Native States of Proteins
  • 9.4 Prediction of the Cellular Toxicity of Protein Aggregates
  • 9.5 Relationship to Other Methods of Predicting Protein Aggregation Propensities
  • 9.6 Competition between Folding and Aggregation of Proteins
  • 9.7 Prediction of Protein Solubility from the Competition between Folding and Aggregation
  • 9.7.1 Sequence-Based Prediction of Protein Solubility
  • 9.7.2 Prediction of the Solubility of Proteins Based on Their Cellular Abundance
  • 9.8 Sequence-Based Prediction of Protein Interactions with Molecular Chaperones
  • 9.9 Summary
  • References
  • 10 The Kinetics and Mechanisms of Amyloid Formation
  • 10.1 Introduction
  • 10.2 Classical Theory of Nucleated Polymerization
  • 10.2.1 From Microscopic Processes to a Master Equation
  • 10.2.2 Kinetic Equations for Experimental Observables
  • 10.2.3 Characteristics of Oosawa-Type Growth
  • 10.2.3.1 Nucleation and Growth Occur Simultaneously
  • 10.2.3.2 The Early Stages of the Reaction Time Course Are Described by Polynomial Growth
  • 10.2.3.3 The Late Stages of the Reaction Time Course are Described by Simple First-Order Kinetics
  • 10.2.3.4 The Integrated Rate Laws Exhibit Scaling Behavior
  • 10.2.4 Global Analysis of Experimental Data Using the Oosawa Theory
  • 10.3 The Theory of Filamentous Growth with Secondary Pathways
  • 10.3.1 Extending the Oosawa Framework to Include Fragmentation and Secondary Nucleation
  • 10.3.2 Early Time Perturbative Solutions.
  • 10.3.3 Characteristics of Exponential-Type Growth
  • 10.3.3.1 The Early Stages of the Reaction Time Course Are Exponential
  • 10.3.3.2 The Solution Exhibits Scaling Behavior
  • 10.3.4 Global Analysis of Experimental Data Using Linearized Solutions
  • 10.4 Self-Consistent Solutions for the Complete Reaction Time Course
  • 10.4.1 The Key Phenomenological Parameters Depend on Combinations of the Microscopic Rate Constants
  • 10.4.2 Reaction Time Course with Depleted Monomer Concentration
  • 10.4.3 Global Analysis of Amyloid Reaction Kinetics Using Self-Consistent Solutions
  • 10.5 Summary
  • References
  • 11 Fluorescence Spectroscopy as a Tool to Characterize Amyloid Oligomers and Fibrils
  • 11.1 Introduction
  • 11.2 Fluorescence Spectroscopy for Studies of Amyloid Reactions In vitro
  • 11.2.1 Fluorescence Output Formats
  • 11.2.2 Fluorescence Anisotropy
  • 11.2.3 Single Molecule Detection
  • 11.2.4 Conformational Probes
  • 11.3 Cysteine-Reactive Fluorescent Probes
  • 11.3.1 Environmentally Sensitive Probes
  • Spectrochromic Stokes Shift Assay
  • 11.3.2 Fluorescence Anisotropy Probes for Amyloid Oligomerization
  • 11.3.3 Pyrene Excimer Formation Probes for amyloid Oligomer and Fibril Topology
  • 11.3.4 Bifunctional Cysteine Reagents as Probes for Amyloid Oligomers and Fibrils
  • 11.4 Amyloidotropic Probes for Amyloid Fibrils and Oligomeric States
  • 11.4.1 Are There Selective Probes for Prefibrillar Oligomeric States?
  • 11.4.2 Fluorescence Anisotropy of Small Molecule Probes for Capturing the Intermediate Oligomeric State
  • 11.4.3 In vivo Fluorescent Probes for Amyloid Fibrils
  • 11.5 Luminescent Conjugated Poly and Oligothiophenes LCPs and LCOs
  • 11.5.1 Optical Properties of Chemically Defined LCOs
  • 11.5.2 Bridging the Imaging and Spectroscopy Gap
  • Microspectroscopy of In vivo Formed Amyloids.